Blocking of EGFR Signaling is a Latent Strategy for the Improvement of Prognosis of HPV Induced Cancer
J. Qiu, F. Hu, T. Shao, Y. Guo, Z. Dai, H. Nie, O. I. Olasunkanmi, Y. Chen, L. Lin, W. Zhao, Z. Zhong, Y. Wang
This study identifies EGFR downregulation as a mechanism by which HPV infection improves prognosis in cervical and head and neck cancers, suggesting EGFR inhibitors could be potential anti-HPV therapies.
bioRxiv · Oct 6, 2020 · PreprintMicrobiology